Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,141 | -3,470 | -6,843 | -4,044 | -1,714 |
| Depreciation Amortization | 44 | 22 | 43 | 14 | 6 |
| Other Working Capital | 617 | -561 | 432 | -695 | 117 |
| Other Operating Activity | 159 | 61 | 1,102 | 1,060 | 994 |
| Operating Cash Flow | $-7,321 | $-3,949 | $-5,267 | $-3,666 | $-598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -31 | -252 | -169 | -98 |
| Investing Cash Flow | $-73 | $-31 | $-252 | $-169 | $-98 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 6 | 26,335 | 26,335 | N/A |
| Other Financing Activity | 0 | 0 | -819 | -828 | -53 |
| Financing Cash Flow | $6 | $6 | $25,517 | $25,507 | $-53 |
| Beginning Cash Position | 20,826 | 20,826 | 828 | 828 | 828 |
| End Cash Position | 13,438 | 16,853 | 20,826 | 22,500 | 80 |
| Net Cash Flow | $-7,388 | $-3,973 | $19,998 | $21,672 | $-748 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,321 | -3,949 | -5,267 | -3,666 | -598 |
| Capital Expenditure | -73 | -31 | -255 | -169 | -98 |
| Free Cash Flow | -7,394 | -3,979 | -5,522 | -3,835 | -696 |